Breaking News Instant updates and real-time market news.

CRM

Salesforce

$68.42

-4.21 (-5.80%)

, TWTR

Twitter

$24.87

1.35 (5.74%)

06:02
10/06/16
10/06
06:02
10/06/16
06:02

Citi says Salesforce buying Twitter 'nearly impossible' above $28/share

Citi analyst Walter Pritchard believes a Salesforce (CRM) acquisition of Twitter (TWTR) is possible financially but that such a deal would put "significant constraints" on the company for the next three-plus years. The analyst sees "very little reason" for Salesforce to own Twitter and feels the acquisition "would pose a difficult decision" for CEO Marc Benioff and the board. Salesforce closed yesterday down 6%, or $4.21, to $68.42. Recode reported last night that the company is likely the only bidder left for Twitter after Disney (DIS) and Alphabet (GOOG) opted not to pursue a deal while Apple (AAPL) is unlikely. Twitter in pre-market trading is down 14% to $21.50. In order for Salesforce to avoid a shareholder vote, it would have to borrow $7.5B to fund the transaction if Twitter were valued at $20B, or $27.50-$28 per share, Pritchard tells investors in a research note. This is a level that likely constrains the company with little additional borrowing capacity for other deals, the analyst contends. He thinks the deal is "nearly impossible to do" for Salesforce should the bidding for Twitter go above $20B or $28 per share. Pritchard has a Buy rating on Salesforce with an $89 price target.

CRM

Salesforce

$68.42

-4.21 (-5.80%)

TWTR

Twitter

$24.87

1.35 (5.74%)

DIS

Disney

$92.45

-0.14 (-0.15%)

AAPL

Apple

$113.05

0.05 (0.04%)

GOOG

Alphabet

$776.47

0.04 (0.01%)

GOOGL

Alphabet Class A

$801.23

-1.56 (-0.19%)

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 10

    Nov

  • 10

    Nov

  • 30

    Nov

  • 15

    Jan

CRM Salesforce
$68.42

-4.21 (-5.80%)

10/05/16
STFL
10/05/16
NO CHANGE
Target $93
STFL
Buy
Stifel still sees Salesforce acquisition of Twitter as 'highly unlikely'
Stifel analyst Tom Roderick notes that Salesforce (CRM) kicked off its annual Dreamforce User Conference yesterday amid reports that the company may be a potential suitor for Twitter (TWTR). The analyst still believes that a Salesforce acquisition of Twitter is "highly unlikely," both from a logistical standpoint and from a business model fit perspective. Regarding fundamentals, Roderick continues to view Salesforce as a leading driver of the enterprise shift to the Cloud, and sees no reason why that shouldn't continue to play out in the second half of 2017, in spite of recent concerns about the mid-year slowdown. He reiterates a Buy rating and $93 price target on Salesforce's shares.
10/05/16
BMOC
10/05/16
NO CHANGE
BMOC
Outperform
BMO says Salesforce's positive messages overshadowed by Twitter speculation
BMO Capital analyst Keith Bachman said the positive themes laid out by Salesforce (CRM) management at the company's Dreamforce event, such as guidance to reach $10B in FY18 revenues without inorganic sources of revenue, would traditionally help the stock. However, news reports, including the most recent from the Wall Street Journal, indicating that the company may buy Twitter (TWTR), will outweigh the "positive messages" of the event. If Salesforce were to buy Twitter, the stock would move meaningfully lower, Bachman predicted, but he also wonders if strategic buyers would then potentially consider buying Salesforce. The firm keeps its Outperform rating on Salesforce shares.
10/05/16
BOFA
10/05/16
NO CHANGE
Target $100
BOFA
Buy
Salesforce acquisition of Twitter 'quite low,' says BofA/Merrill
BofA/Merrill analyst Kash Rangan said the probability of Salesforce (CRM) acquiring Twitter (TWTR) is "quite low." The analyst does not believe Salesforce would materially dilute its shareholders with such a risky deal and expects the CEO to provide clarity on the thought process behind core software acquisitions versus media at today's Q&A session. Rangan rates Salesforce a Buy with a $100 price target on shares.
10/05/16
JPMS
10/05/16
NO CHANGE
Target $95
JPMS
Overweight
JPMorgan backs Overweight rating on Salesforce as Twitter speculation gears up
JPMorgan analyst Mark Murphy noted that speculation that Salesforce (CRM) could buy Twitter (TWTR) has ratcheted up into a higher gear, fueled by the latest report from the WSJ, and acknowledges the risk of a setback if the company goes forward with such a transformational M&A deal. However, he still views Salesforce as a "rare cloud asset" that can be a long-term share gainer and keeps an Overweight rating and $95 price target on the shares.
TWTR Twitter
$24.87

1.35 (5.74%)

10/05/16
WEDB
10/05/16
NO CHANGE
WEDB
Outperform
Twitter worries obscuring positive trends for Salesforce, says Wedbush
Wedbush analyst Steve Koenig said his industry and partner checks don't point to any secular headwinds for Salesforce's (CRM) business, adding that the company gave several reassuring metrics on its progress in cross-selling, growing deal sizes, and expanding its large account base at its investor day event at the Dreamforce conference. At the investor day, management acknowledged conjecture about Salesforce trying to buy Twitter (TWTR), but deflected comments, with CFO Mark Hawkins suggesting that CEO Marc Benioff's Q&A session Wednesday afternoon may be a better forum for soliciting comments, noted Koenig. The analyst, who remains constructive on Salesforce as long as the company doesn't buy Twitter, keeps an Outperform rating on the shares.
DIS Disney
$92.45

-0.14 (-0.15%)

09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.
09/28/16
SBSH
09/28/16
NO CHANGE
SBSH
Buy
Citi hopes Disney does not acquire Twitter
Citi analyst Jason Bazinet lays out four reasons for why he doesn't like Disney (DIS) pursuing an acquisition of Twitter (TWTR). Going back 15 years, the analyst can't think of a single web-based property that was successfully acquired by a traditional media firm. Two, he calls Twitter trends "troubling." Three, Bazinet estimates a cash offer would lower Disney's stock by $5 per share while an equity offer would drop its stock by $9. Four, the analyst feels it is unclear how Disney's content will help Twitter. Bazinet thinks both Yahoo (YHOO) and Twitter lost "significant money" when they streamed NFL content over the web. The analyst hopes Twitter is acquired by somebody other than Disney. He keeps a Buy rating on Disney shares. Both Loop Capital and Mizuho this morning downgraded Twitter to sell ratings.
09/27/16
SBSH
09/27/16
NO CHANGE
Target $16
SBSH
Neutral
Citi sees 40% downside in Twitter with no takeover bid
Citi analyst Mark May believes Twitter's (TWTR) risk/reward skews to the downside following the recent rally in the shares. A buyout of the company carries "strategic rationale for certain companies," but Twitter's "struggles and steep valuation" make a deal at a meaningful premium less likely, May tells investors in a research note. A takeover at $26 per share looks aggressive, May contends. He believes the stock could retest the lows of late May, representing 40% downside from current levels, should an acquisition offer not materialize. The analyst keeps a Neutral rating on Twitter with a $16 price target. The shares closed yesterday up 75c to $23.37 following reports that Disney (DIS) may be joining the list of potential acquires that already includes Alphabet (GOOG) and Salesforce (CRM).
09/26/16
09/26/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Hold from Buy at Drexel Hamilton with analyst Tony Wible saying he believes a large step up in NBA costs, incremental subscribers losses, difficult studio comps, a riskier studio slate, and Shanghai cost pressures will weigh on fiscal 2017. 2. Twitter (TWTR) downgraded to Underperform from Perform at Oppenheimer with analyst Jason Helfstein saying a media company is the most likely acquirer of Twitter and would not pay meaningfully more than the valuation implied by our price target. 3. RetailMeNot (SALE) downgraded to Sell from Hold at Stifel with analyst Scott Devitt saying third party data indicates that the company's traffic trends have deteriorated recently. 4. Finish Line (FINL) downgraded to Neutral from Buy at Buckingham with the firm's analyst believing shares will be range bound in medium term due to high comp expectations, cost savings will be offset by incentive compensation and other investments, and less compelling valuation. 5. NetApp (NTAP) downgraded to Sell from Hold at Deutsche Bank with analyst Sherri Scribner saying secular challenges in the storage market are not reflected in NetApp's current valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AAPL Apple
$113.05

0.05 (0.04%)

10/05/16
10/05/16
NO CHANGE

Bernstein sees no 'compelling rationale' for Apple buying Netflix
Bernstein analyst Toni Sacconaghi says he does not see a "compelling rationale" for Apple (AAPL) acquiring Netflix (NFLX). The steaming service has recently been the subject of takeover speculation, with Disney (DIS) mentioned as a possible suitor. Buying Netflix to run exclusively on Apple's operating service and AppleTV is "not a value-creating thesis and could not possibly justify a $50B price tag," Sacconaghi tells investors in a research note. Apple could buy Netflix and continue to run it as it does today, but that "would be highly out of character" for the iPhone maker, the analyst contends. Sacconaghi believes Apple could get much of the benefit of a services offering with much less upfront risk by partnering with Netflix, rather than acquiring it. He sees a partnership as more likely than a takeover. Further, Sacconaghi thinks a potential a partnership or acquisition by Apple does not justify owning Netflix since a deal is very hard to predict. The analyst has an Outperform rating on Apple and an Underpeform rating on Netflix. He has a $62 price target for Netflix shares. The streaming service closed yesterday down 29c to $102.34.
10/03/16
PIPR
10/03/16
NO CHANGE
Target $151
PIPR
Overweight
Apple checks show iPhone 7 inventory still constrained, says Piper Jaffray
Piper Jaffray analyst Gene Munster said his checks of 134 Apple Stores in the U.S. showed that iPhone 7 and iPhone 7 Plus inventory levels are improved, but still constrained, and that supply appears even tighter in China. The limited supply of the iPhone 7 Plus should bode well for the December quarter outlook, adds Munster, who keeps an Overweight rating and $151 price target on Apple shares.
09/30/16
SBSH
09/30/16
NO CHANGE
Target $130
SBSH
Buy
Apple price target raised to $130 from $120 at Citi
Citi analyst Jim Suva raised his price target for Apple shares to $130 from $120 and keeps a Buy rating on the name. The stock closed yesterday down $1.77 to $112.18. U.S., Canada, European and Asian store checks indicate iPhone 7 demand at launch appears strong, Suva tells investors in a research note. Supply remains a limiting factor with many stores having received very limited supply of the iPhone 7 and in some cases only to suffice demand from preorders, the analyst adds. Suva raised his iPhone estimate for the December quarter to 79.4M units, above the consensus of 75M units.
10/05/16
UBSW
10/05/16
NO CHANGE
Target $127
UBSW
Buy
Apple preparing for next era of personal technology, says UBS
UBS analyst Steve Milunovich notes his residual income model for Apple shows only small growth beyond three years. He believes the current share price reflects the slight annual declines but he thinks the cautious view would be incorrect because Apple is preparing for the next era of personal technology. Milunovich calls the next phase the Ambient Paradigm, which will require hardware, software, and orchestration to provide a seamless experience across all consumer devices. The Apple Watch, AirPods, and possibly other wearables will eventually impact industries such as healthcare and education and could be the next scarcity, said Milunovich, who reiterated his Buy rating and $127 price target on Apple shares.
GOOG Alphabet
$776.47

0.04 (0.01%)

09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
Wedbush analyst James Dix downgraded Alphabet to Underperform and lowered his price target on shares to $700 on concerns the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive.
09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GOOGL Alphabet Class A
$801.23

-1.56 (-0.19%)

09/30/16
RBCM
09/30/16
NO CHANGE
RBCM
Street underestimating Google growth outlook, says RBC Capital
RBC Capital analyst Mark Mahaney expects Google to end 2016 with "up to 20% growth," versus the Street's outlook of mid teen percentage level growth. Mahaney says that Google's growth should be boosted by "ongoing Search innovations, rising Mobile CPCs, and the growing impact of YouTube, Play & Cloud." He thinks that YouTube's revenue is growing at a 30%-40% clip. Mahaney raised his price target on the stock to $1,025 from $1,000 and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

QVCA

QVC Group

$24.61

0.1 (0.41%)

, QVCB

QVC Group

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
FBN Securities media analyst to hold a luncheon meeting »

Media Analyst Routh…

QVCA

QVC Group

$24.61

0.1 (0.41%)

QVCB

QVC Group

LVNTA

Liberty Ventures

$52.69

1.21 (2.35%)

GNCMA

General Communications

$36.81

0.97 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 10

    Jul

ICON

Iconix Brand

$6.88

-0.01 (-0.15%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Iconix Brand management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CIR

CIRCOR

$58.61

0.95 (1.65%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
CIRCOR management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CUTR

Cutera

$26.55

1 (3.91%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cutera management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

  • 28

    Sep

EVLV

EVINE Live

$1.02

-0.02 (-1.92%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
EVINE Live management to meet with Craig-Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FARM

Farmer Bros.

$31.15

1.05 (3.49%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Farmer Bros. management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

AGNC

AGNC Investment

$21.54

-0.16 (-0.74%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
AGNC Investment management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 6/24 Jobless…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

Week of 6/25 Bloomberg…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

NBIX

Neurocrine

$46.77

1.21 (2.66%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Neurocrine management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

CBRL

Cracker Barrel

$167.46

0.74 (0.44%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cracker Barrel management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CRNCY

Cairn Energy

$4.56

0.0998 (2.24%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cairn Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

BAYRY

Bayer

$138.99

1.4 (1.02%)

, FMS

Fresenius Medical

$49.19

0.39 (0.80%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
UBS to hold a bus tour »

European Healthcare Bus…

BAYRY

Bayer

$138.99

1.4 (1.02%)

FMS

Fresenius Medical

$49.19

0.39 (0.80%)

RHHBY

Roche

$32.79

0.21 (0.64%)

NVS

Novartis

$85.25

-0.06 (-0.07%)

BPMUF

Basilea Pharmaceutica AG

$84.80

0.45 (0.53%)

GNMSF

Genmab

AZN

AstraZeneca

$34.35

-0.22 (-0.64%)

SHPG

Shire

$171.81

-0.1 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

  • 12

    Jul

  • 13

    Jul

  • 30

    Jul

CSV

Carriage Services

$26.85

0.06 (0.22%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Carriage Services management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 28

    Sep

WM

Waste Management

$73.52

0.41 (0.56%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Waste Management management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FTV

Fortive

$64.41

1.04 (1.64%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Fortive has a conference call hosted by JPMorgan »

JPMorgan Analyst Tusa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

RGA

Reinsurance Group

$128.86

2 (1.58%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Reinsurance Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SRCL

Stericycle

$77.72

0.48 (0.62%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Stericycle management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 03

    Aug

RVLT

Revolution Lighting

$6.32

-0.05 (-0.78%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Revolution Lighting management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Real GDP to be reported at 08:30 »

Real GDP will be reported…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

Week of 6/28 Fed Balance…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

BIIB

Biogen

$274.64

3.39 (1.25%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Biogen management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 25

    Jul

OXM

Oxford Industries

$62.76

0.92 (1.49%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Oxford Industries management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.